Biotech ETFs In Focus After A Choppy Week

Biotech stocks were able to keep their rally intact until March 25, breezing past the nearly flat broader market indices. However, on March 25, major biotechnology indexes were off over 4%, leading the Nasdaq Composite Index to see its biggest ‘one-day loss in nearly a year’.